GSK and Sanofi Strike Deal with U.K. Government for 60 Million COVID-19 Vaccine Doses

Three months after joining forces to develop an adjuvanted vaccine for COVID-19, Sanofi and GlaxoSmithKline reached an agreement with the U.K. government to provide up to 60 million doses of the preventative medication.